Industry news

2022 01.17
Tigermed-Jyton Accelerates Approval of China’s First Full Magnetic Suspension Artificial Heart—New Hope for Patients with Advanced Heart Failure

Home Prev 1 Next End
Advance Human Health through
Delivery Excellence
Subscribe to Receive Tigermed-Jyton's Regulatory Newsletter

Obtain the latest industry and regulatory updates on a monthly basis.

I would like to receive Tigermed-Jyton's Regulatory Newsletter. Tigermed-Jyton guarantees that the above information will not be used for other purposes.

Tel：400-0739-391

Email：consult@tigermedgrp.com

Add：HANGZHOU

China Postal Code：310051

About Us
Service & Tech
News
Contact

Copyright © 2017-2022 Tigermed-Jyton All Rights Reserved.

京ICP备2021039767号

Cookies

TOP
Contacts
Cookies
The site uses cookies in order to collect data to provide general statistics to optimize site functionality and offer you a better experience. For more information, visit our Privacy Policy.